| Ono Pharmaceutical Co., Ltd. - SWOT Analysis | | | | latest available statement from Ono |
| company profile is the essential source for | | | | Pharmaceutical Co., Ltd. |
| top-level company data and information. Ono | | | | Reasons to Purchase |
| Pharmaceutical Co., Ltd. - SWOT Analysis | | | | - Support sales activities by understanding your |
| examines the company's key business structure | | | | customers' businesses better |
| and operations, history and products, and provides | | | | - Qualify prospective partners and suppliers |
| summary analysis of its key revenue lines and | | | | - Keep fully up to date on your competitors' |
| strategy. | | | | business structure, strategy and prospects |
| Ono Pharmaceutical (Ono) is engaged in the | | | | - Obtain the most up to date company |
| production, purchase and sale of pharmaceuticals | | | | information available" |
| and diagnostic reagents focusing primarily on | | | | Table of Contents : |
| prescription pharmaceuticals. It offers drugs for | | | | This product typically includes the following |
| the treatment of bronchial asthma, diabetic | | | | sections: |
| peripheral neuropathy, intraoperative and | | | | SWOT COMPANY PROFILE: Ono Pharmaceutical |
| postoperative tachyarrhythmia and overactive | | | | Co., Ltd. |
| bladder. The company primarily operates in Japan. | | | | Key Facts: Ono Pharmaceutical Co., Ltd. |
| It is headquartered in Osaka, Japan and employed | | | | Company Overview: Ono Pharmaceutical Co., Ltd. |
| 2,646 people as of March 2009. The company | | | | Business Description: Ono Pharmaceutical Co., Ltd. |
| recorded revenues of JPY136,557 million ($1,365.6 | | | | Company History: Ono Pharmaceutical Co., Ltd. |
| million) during the financial year (FY) ended March | | | | Key Employees: Ono Pharmaceutical Co., Ltd. |
| 2009, a decrease of 6.4% over FY2008. The | | | | Key Employee Biographies: Ono Pharmaceutical |
| operating profit of the company was JPY43,472 | | | | Co., Ltd. |
| million ($434.7 million) during FY2009, a decrease | | | | Products & Services Listing: Ono |
| of 16.9% over FY2008. The net profit of the | | | | Pharmaceutical Co., Ltd. |
| company was JPY23,767 million ($237.7 million) in | | | | Products & Services Analysis: Ono |
| FY2009, a decrease of 32.2% over FY2008. | | | | Pharmaceutical Co., Ltd. |
| Scope of the Report | | | | SWOT analysis: Ono Pharmaceutical Co., Ltd. |
| - Provides all the crucial information on Ono | | | | *Strengths: Ono Pharmaceutical Co., Ltd. |
| Pharmaceutical Co., Ltd. required for business and | | | | *Weaknesses: Ono Pharmaceutical Co., Ltd. |
| competitor intelligence needs | | | | *Opportunities: Ono Pharmaceutical Co., Ltd. |
| - Contains a study of the major internal and | | | | *Threats: Ono Pharmaceutical Co., Ltd. |
| external factors affecting Ono Pharmaceutical Co., | | | | Company View: Ono Pharmaceutical Co., Ltd. |
| Ltd. in the form of a SWOT analysis as well as a | | | | Top Competitors: Ono Pharmaceutical Co., Ltd. |
| breakdown and examination of leading product | | | | Location and Subsidiary: Ono Pharmaceutical Co., |
| revenue streams of Ono Pharmaceutical Co., Ltd. | | | | Ltd. |
| -Data is supplemented with details on Ono | | | | *Head Office: Ono Pharmaceutical Co., Ltd. |
| Pharmaceutical Co., Ltd. history, key executives, | | | | *Other Locations and Subsidiaries: Ono |
| business description, locations and subsidiaries as | | | | Pharmaceutical Co., Ltd. |
| well as a list of products and services and the | | | | |